Brain shuttle peptides derived from phage display

Area of Science:

• Molecular biology
• Neuroscience
• Biotechnology

Background:

• Vascular beds show molecular differences across tissues, including the brain.
• Phage display is a technique used to discover peptide ligands for specific tissues.
• Peptide ligands can facilitate targeted drug delivery across biological barriers.

Purpose of the Study:

• To explore the use of in vivo phage display for discovering tissue-specific peptide ligands.
• To identify peptides that can cross the blood-brain barrier (BBB).
• To assess the potential of these peptides in preclinical therapeutic applications for brain disorders.

Main Methods:

• In vivo phage display screening of peptide libraries.
• In vitro phage display using models like BBB models, cultured cells, and immobilized receptors.
• Identification and characterization of peptide-receptor interactions, such as the transferrin receptor (TfR) complex.

Main Results:

• Discovery of the iron-mimicking peptide CRTIGPSVC, which binds to the transferrin/transferrin receptor (TfR) complex for BBB transport.
• Identification of various other brain-homing and BBB-crossing peptides through phage display.
• Demonstration of preclinical therapeutic applications for brain disorders using identified peptides.

Conclusions:

• Phage display is effective in discovering peptides that target specific tissues and cross the BBB.
• The identified peptides show promise for developing targeted brain therapies.
• Further research using phage display will enhance understanding of BBB transport and advance brain-targeted treatments.